RxDoctor Payments Data

Stuart Gold

Pediatric Hematology-Oncology · Chapel Hill, NCNPI 1841380557

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $9,382 of the $9,382 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Stryker.

$9,382in general payments, 2019–2025

Across 8 payments — averaging $1172.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$9K
$694,497in research payments, 2019–2025

Across 79 payments — averaging $8791.10 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Jazz Pharmaceuticals Inc.$422K
  • Novartis$98K
  • Merck$76K
  • E.r. Squibb & Sons, L.L.C.$76K
  • Amgen$18K
  • Incyte Corporation$4K

What the payments were for

  • Travel & lodging$9,382100%

General payments by program year

21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stryker8$9,382

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,382 in reported general payments places this provider in the 60th percentile of 57 pediatric hematology-oncology providers in North Carolina.

See all pediatric hematology-oncology providers in North Carolina

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dexamethasone11$727

Paid to pharmacies, not to this prescriber.

Other pediatric hematology-oncology in Chapel Hill

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →